The current study follows angiogenesis and micro circulatory changes associated with malignant glioma growth by means of an intravital fluorescence microscopic approach, which allows for the direct and continuous visualization of the glioma microvasculature and its quantitative analysis. Fluores cently labeled C6 rat glioma cells (5 x 10 5 ) were implanted into dorsal skinfold chamber preparations of athymic nude mice. Glioma growth, vascularization, microhemodynamics, vascular permeability, and leukocyte-endothelial cell interactions were simultaneously followed over a 22-day observation period us ing intravital epiillumination microscopy and a multifluores cent labeling technique. Analysis of the process of glioma vas cularization revealed three stages with distinct microvascular characteristics: avascular stage (days 0 to 6), lag of glioma growth but initial glioma-induced angiogenesis within the host tissue in peritumoral areas; early vascular stage (days 6 to 14), glioma cell proliferation associated with a spatially homoge neous development of a glioma microvasculature; and late vas cular stage (days 14 to 22), exponential tumor growth and expansion (> 400 mm 3 ) with high vascular densities in the Marked microvascular proliferation, indicating a high degree of neoangiogenesis, is a characteristic histologic feature of malignant glioma (Deane and Lantos, 1981) and has been shown to be of prognostic value in patients with astroglial tumors (Leon et aI" 1996). Without this continuous formation of new blood vessels, malignant gliomas do not progress to a clinically relevant size be-Abbreviations used: FITC, fluorescein isothiocyanate; Mw, molecu lar weight; VEGFIVPF, vascular endothelial growth factor/vascular permeability factor. 510 peritumoral region and reduced vascularization (microvascular perfusion) in the glioma center, Within the center, the func tional vessel length per area correlated inversely with glioma size (P < 0.01). In the peritumoral region, functional vessel length per area was independent of glioma size, indicating per sistent, high angiogenic activity throughout the observation pe riod. Thus, the microvasculature of mature gliomas revealed a microvascular zonal division with a progressive reduction of the functional vessel length per area within the tumor center, The perfusion failure of individual microvessels within the glioma center was partly compensated by an increase of diam eters (P < 0.05), and thus by an increase of blood flow in these functional microvessels (P < 0.05) over time. Histologic analy sis demonstrated both expanding and infiltrating growth pat terns, as well as focal necroses on day 22. These are the first data from repeated in vivo analysis of glioma growth, vascu larization, and microcirculation. Key Words: C6 rat glioma Intravital fluorescence microscopy-Microvascular permeabil ity-Vascularization.
Summary:
The current study follows angiogenesis and micro circulatory changes associated with malignant glioma growth by means of an intravital fluorescence microscopic approach, which allows for the direct and continuous visualization of the glioma microvasculature and its quantitative analysis. Fluores cently labeled C6 rat glioma cells (5 x 10 5 ) were implanted into dorsal skinfold chamber preparations of athymic nude mice. Glioma growth, vascularization, microhemodynamics, vascular permeability, and leukocyte-endothelial cell interactions were simultaneously followed over a 22-day observation period us ing intravital epiillumination microscopy and a multifluores cent labeling technique. Analysis of the process of glioma vas cularization revealed three stages with distinct microvascular characteristics: avascular stage (days 0 to 6), lag of glioma growth but initial glioma-induced angiogenesis within the host tissue in peritumoral areas; early vascular stage (days 6 to 14), glioma cell proliferation associated with a spatially homoge neous development of a glioma microvasculature; and late vas cular stage (days 14 to 22), exponential tumor growth and expansion (> 400 mm 3 ) with high vascular densities in the Marked microvascular proliferation, indicating a high degree of neoangiogenesis, is a characteristic histologic feature of malignant glioma (Deane and Lantos, 1981) and has been shown to be of prognostic value in patients with astroglial tumors (Leon et aI" 1996) . Without this continuous formation of new blood vessels, malignant gliomas do not progress to a clinically relevant size be-peritumoral region and reduced vascularization (microvascular perfusion) in the glioma center, Within the center, the func tional vessel length per area correlated inversely with glioma size (P < 0.01). In the peritumoral region, functional vessel length per area was independent of glioma size, indicating per sistent, high angiogenic activity throughout the observation pe riod. Thus, the microvasculature of mature gliomas revealed a microvascular zonal division with a progressive reduction of the functional vessel length per area within the tumor center, The perfusion failure of individual microvessels within the glioma center was partly compensated by an increase of diam eters (P < 0.05), and thus by an increase of blood flow in these functional microvessels (P < 0.05) over time. Histologic analy sis demonstrated both expanding and infiltrating growth pat terns, as well as focal necroses on day 22. These are the first data from repeated in vivo analysis of glioma growth, vascu larization, and microcirculation. Key Words: C6 rat glioma Intravital fluorescence microscopy-Microvascular permeabil ity-Vascularization. cause of limitations in oxygen and nutritional supply (Folkman, 1990; Millauer et aI., 1994) . Induction of glioma neoangiogenesis seems to be based on genetic transformation of glioma cells (Abe et aI" 1993) , or on intratumoral hypoxia or nutritional deficiency (Ikeda et aI" 1995; Shweiki et aI" 1995) . So far, numerous angio genic factors have been identified in human brain tumor biopsy material (Stefanik et aI" 1991; Plate et aI" 1992; Plate et aI" 1994) . Accordingly, several novel angiostatic approaches have been proposed for glioma therapy (Mil lauer et aI" 1994; Takamiya et aI" 1994; Stan et aI" 1995) . In addition to glioma angiogenesis, changes in glioma microcirculation play an important role for thera peutic considerations. The efficacy of radiotherapy gen erally depends on local tissue P0 2 (Bedford and Mitchell, 1974) , which is determined by local microvascular blood flow. Moreover, blood flow and microvascular perme ability are of major importance for the delivery of tu moricidal agents in chemotherapy (Sands et aI. , 1988) .
Despite this impact of the vascular compartment on glioma physiologic makeup and potential therapeutic strategies, there is still a significant lack in the under standing of the complex mechanisms underlying glioma angiogenesis and changes in glioma microcirculation. This is partly because of limitations of available assays to adequately reflect the dynamic relation between glioma growth , angiogenesis, and microcirculation. Studies performed in vitro address glioma angiogenesis by analyzing the attachment of endothelial cells to matrix proteins, microvascular proliferation, and vascular tube formation in response to glioma cell-conditioned media (Abe et aI. , 1993; Nida et aI. , 1995) . Studies based on in vivo experiments evaluate glioma angiogenesis and mi crocirculation solely by indirect techniques such as his tologic vessel counts (Wesseling et aI. , 1994) , three dimensional vascular corrosion casts (Orita et aI. , 1988) , microangiography by injection of dyes (Bernsen et aI. , 1995) , and blood flow measurements applying [14C] iodoantipyrine autoradiography (Whittle et aI. , 1996) , 133 Xe-washout (Andrade et aI. , 1992) , Laser-Doppler flowmetry (Foltz et aI. , 1995) , or perfusion-weighted magnetic resonance microimaging (Abramovitch et aI. , 1995) . Taken together, these procedures have distinct disadvantages. Postmortem approaches are invasive, lim ited to a single observation time point, and bear the dan ger of artefacts arising from methodologic problems or fi xation techniques. Laser Doppler flowmetry and mag netic resonance micro imaging provide only a low spatial re solution, with little information on distinct vascular development.
Intravital microscopy represents an ideal tool to quan titatively assess the dynamic process of angiogenesis and microvascular perfusion of normal and neoplastic tissue (Leunig et aI., 1992; Menger et aI. , 1994; Vajkoczy et a!. , 1995a Vajkoczy et a!. , , 1995b Vajkoczy et a!. , , 1997 . It allows for a direct, continuous, and noninvasive visualization of the microvasculature at the level of individual microvessels and for quantitative evaluation of microhemodynamic parameters. Yuan and others (1994) and Foltz and colleagues (1995) reported the intravital microscopic analysis of malignant gliomas transplanted into a cranial window preparation. This model, although elegant with the pia as the host tissue, is limited to the visualization of a fully developed glioma microvasculature at one individual time point, and does not allow for a detailed analysis of the dynamic process of angiogenesis induced by proliferating glioma cells. Thus, these studies failed to demonstrate the relation of glioma growth and microcirculation in a chronic model over time. This, however, is of essential interest, espe cially in the early stages of tumor growth when subtle alterations are difficult to visualize.
To further address this objective, we developed a non invasive, in vivo model that allows for the simultaneous and repetitive analysis of malignant glioma growth, an giogenesis, and microcirculation. With the use of the dorsal skinfold chamber preparation in the nude mouse (Vajkoczy et a!. , 1995a) and the transplantable C6 rat glioma cell line, intravital epiillumination microscopic study, coupled with a multiple-fluorochrome labeling technique, allowed for simultaneous visualization of in dividual proliferating glioma cells, angiogenic microves sels, and circulating leukocytes over a period of up to 3 weeks. With respect to glioma growth, we report the characteristics of glioma angiogenesis and microcircula tion in terms of total and functional vascular densities, vessel diameter, red blood cell velocity, microvascular blood flow, microvascular permeability, and leukocyte endothelial cell interaction.
METHODS

Animal and tumor model
The experiments were performed in athymic, adult nude mice (nu/nu; male, 28 to 32 g), bred and maintained within a specific pathogen-free environment. The microsurgical tech niques for the implantation of the dorsal skin fold chambers, as well as for the indwelling venous catheters, have been previ ously described in detail (Vajkoczy et a1., 1995a) . Briefly, ani mals were anesthetized with ketamine/xylazine (7.5 mg keta mine hydrochloride and 2.5 mg xylazine/lOO mg body weight, subcutaneously). Using microsurgical techniques, two sym metrical titanium frames were implanted into the dorsal skin fold so as to sandwich the extended double layer of skin. One layer was completely removed in a circular area of 15 mm in diameter, and the remaining layer, consisting of striated muscle, subcutaneous tissue, and epidermis, was covered with a glass coverslip incorporated into one of the frames. This observation window allows for repeated intravital microscopic observations of the microvasculature. The backside of the preparation is open, thus allowing a three-dimensional growth pattern of the implanted glioma cells. To eliminate the effects of surgical trauma, chambers were implanted 2 days before glioma cell implantation. The animals tolerated the skinfold chamber well and showed no signs of discomfort. In particular, no effects on sleeping and feeding habits were observed. For administration of fluorescent markers, a fine polyethylene cath eter was inserted into the jugular vein, passed subcutaneously to the dorsal side of the neck, and sutured to the titanium frames.
The C6 rat glioma cell line, generated by exposure of rats to N-nitrosomethylurea, has been used extensively as an glial neo plasm model in the nude mouse (Peterson et a1., 1994) . The glioma cells were frozen in HAM's F-IO culture medium with 10% DMSO, grown in HAM's F-IO culture medium, and plated in 12-well dishes for incubation in a 5% carbon dioxide humidified atmosphere at 37°C. For glioma cell implantation, awake animals were restrained in a plexiglass tube. The cov erslip of the dorsal skinfold chamber was temporarily removed, and a dense glioma cell suspension was placed directly onto the surface of the striated skin muscle. Before tumor inoculation, C6 glioma cells were incubated for 2 hours with the fluorescent neuronal tracer Fast Blue (Kuypers and Huisman, 1984 ; Sigma Chemical Co., St. Louis, MO, U.S.A.). The tracer is taken up by both mitochondria and nucleus of all cells when exposed to Fast Blue-containing medium and is characterized by a bright blue fluorescence with only little bleaching at an excitation wave length of 365 nm (Chicoine and Silbergeld, 1995) . Pilot in vitro studies revealed that the fluorescence persists through several cell generations for up to 3 weeks without affecting cell viability.
Intravital microscopy
After cell inoculation, glioma growth and vascularization were documented daily by photomicroscopic study. Repeated intravital fluorescence microscopy (epiillumination) was per formed on days 6, 10, 14, 18, and 22 after glioma cell implan tation using a modified Axiotech Vario microscope with a 100-W mercury lamp attached to a Ploema-Pak illuminator with an ultraviolet (excitation wave length: 340 to 380 nm), a blue (450 to 490 nm), and a green (520 to 570 nm) filter block (Zeiss, Oberkochen, Germany). For this purpose, the animals were anesthetized (7.5 mg ketamine hydrochloride and 2.5 mg xylazine/100 mg body weight, subcutaneously), immobilized in a plexiglass tube, and the chamber preparations were placed on the microscope stage. Observations were made using x3.2 long-distance, xlO long-distance, and x20 water immersion working objectives (all Zeiss, Oberkochem, Germany), result ing in magnifications of x71, x216, and x435, respectively. To standardize the repeated intravital microscopy of the heteroge neous glioma microvasculature, the tumor mass and the pcri tumoral tissue were divided into three radial zones (peritu moral, marginal, and central) at high magnification using the x20 water immersion working objective. On each day, the newly formed microvasculature was investigated individually within these distinct zones (two to three fields zone), resulting in a total of six to nine measurements per animal and per observation time point. Microscopic images were recorded by means of a low-light level charge-coupled device video camera (Cohu FK 6990, Pieper, Schwerte, Germany) and were trans ferred to a S-VHS video system (Panasonic, Munich, Germany) for off-line evaluation. Fast Blue labeling of glioma cells al lowed for precise delineation of the glioma from the surround ing, unaffected host tissue with ultraviolet light epiillumination. By contrast enhancement with 2% fluorescein isothiocyanate (FITC)-dextran (0.1 mL FITC-dextran150 intravenously; mo lecular weight [Mwl = 150,000; Sigma) and use of the blue light epiillumination, angiogenic sprouts, individual microves sels, and, finally, the glioma microvasculature were visualized. Furthermore, extravasation of FITC-dextran150 allowed for an estimate of the microvascular permeability to circulating mac romolecules throughout the observation period. Simultaneous in vivo staining of leukocytes with 0.2% rhodamine 6G (0.1 mL intravenously; Sigma) and the use of green light epii11umi nation enabled sequential analysis of leukocyte-endothelial cell interaction within individual glioma microvessels. In addition to these repeated intravital microscopic observations of the glioma microvasculature, glioma vessel permeability to circu lating molecules in mature gliomas was assessed in detail on days 18 and 22. Therefore, fluorescent markers with distinct mean molecular weights (Na-fluorescein, Mw = 376) and FITC-dextrans (FITC-dextran 150 and FITC-dextransoo, Mw = 500,000, respectively) (all Sigma) were injected intravenously. Extravasation of the test molecules was analyzed 5, 15, and 30 minutes after administration, applying the following semiquan titative score: no extravasation (-); moderate extravasation (in creased extravasal gray levels without negatively contrasted microvascular imaging) forming a patchy (+) or homogeneous (++) pattern; extravasation with negatively contrasted micro vascular imaging (+++).
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Analysis of parameters
Glioma growth was assessed by measurements of the area covered by the glioma mass within the chamber (mm2) and the tumor volume (mm 3 ), which was calculated according to V = 2/, X A x h, where A is the area of the glioma mass and h the thickness of the glioma bulging out at the chamber backside. Quantitative analysis of microcirculatory parameters included the area containing newly formed microvessels (mm2), the total vessel length per area (cm-I) (defined as length of all newly formed microvessels per area of interest and observation time point), the functional vessel length per area (cm-I) (defined as length of red blood cell perfused microvessels per area of in terest and observation time point), micro vessel diameters (f..l m), and microvascular red blood cell velocities (f..l m/second). All measurements were performed by means of a computer assisted image analysis system (CAPIMAGE, Zeintl Software Engineering, Heidelberg, Germany). Newly formed glioma mi crovessels were not categorized into arterioles, capillaries, and venules, since this classification is based on morphologic and physiologic criteria for normal tissue and might thus not be applicable to tumors (Jain, 1988) . A perfusion index (PI) was calculated as the percentage of the functional vessel length per area (FVL) and total vessel length per area (TVL) as follows: PI = FVLITVL x 100. Blood flow rate Qv (nL/second) of individual microvessels was calculated according to Qv = 7T X (D/2)2 x RBCV/K, where RBCV represents the red blood cell velocity, D the microvessel diameter, and K ( = 1.3) the Baker/ Wayland factor (Baker and Wayland, 1974) considering the parabolic velocity profile of blood in microvessels.
Histology and immunohistochemistry
At the end of the in vivo experiments, the animals were killed, and the chamber tissue was excised and processed for histologic and immunohistochemical analysis. The specimens were fixed with 10% paraformaldehyde and embedded in par affin. For conventional histologic study, 3-f..l m sections were stained with hematoxylin-eosin. For immunohistochemical de tection of the glial fibrillary acidic protein and S-IOO protein, 3-f..l m sections were incubated with appropriately diluted anti glial fibrillary acidic protein (1:1 00) and anti-S-IOO protein (1 :300) antibodies (both Dako, Hamburg, Germany) and with biotinylated secondary antibodies. Specimens were finally in cubated with avidin-biotin-horseradish complex (Vector Labo ratories, Burlingame, CA, U.S.A.), developed with Fast Red (Sigma), and counterstained with Hemalaun (Merck, Darm stadt, Germany). Controls were performed without primary and secondary antibodies to exclude nonspecific staining.
Statistical analysis
Quantitative data are given as mean values ± standard de viation. Mean values of microcirculatory data were calculated from the average values in each animal. Comparisons of de pendent variables over the observation period were tested using the paired Student's t test and Bonferroni probabilities for re peated measurements. Interrelations between glioma size and glioma microcirculation were assessed with univariate linear regression analysis. Results with P < 0.05 were considered significant.
RESULTS
Pilot studies
Initially, pilot studies were performed to establish and standardize the glioma model in the dorsal skinfold chamber of nude mice. In these experiments, the number of implanted C 6 glioma cells was titrated between 5 x 10 4 and 5 x 10 6 glioma cells, aiming at a sufficient take rate of the tumors, a high optical quality enabling visu alization of early angiogenic response during the first days of glioma vascularization, and adjustment of glioma growth characteristics to the finite lifetime (3 to 4 weeks) of the chamber preparation.
The pilot studies revealed that after implantation of 5
x 10 4 glioma cells, tumor growth and angiogenic re sponse were markedly retarded during the initial 14 days, thus resulting in a relatively small glioma mass at the end of the 22-day observation period. In contrast, after im plantation of 5 x 10 6 glioma cells, the glioma mass rap idly overgrew the chamber size, and optical quality for intravital microscopic observations was poor because of the dense glioma cell mass overlying the microvascula ture of the host tissue. Therefore, visualization of glioma angiogenesis was possible only from day 10 to 14 after glioma implantation. Implantation of 5 x 10 5 glioma cells guaranteed both a good optical quality for intravital microscopic analysis of glioma growth and angiogenesis throughout the entire observation period, as well as a tumor growth kinetics that respected the limited lifetime of the chamber preparation (-4 weeks). Therefore, the fo llowing experiments were performed with implanta tion of 5 x 10 5 C 6 glioma cells.
Glioma growth and vascularization
The take rate of the C 6 rat glioma in the chamber preparation of nude mice was 100% (n = 15). Between days 2 and 4 after glioma cell implantation, first signs of glioma-induced angiogenesis were observed. They com prised a dilation and tortuous elongation of host vessels (Fig. 1) , as well as the formation of microvascular sprouts and sinusoidal vessel configurations originating fr om host capillaries and postcapillary venules (Fig. 1) . As verified by the multifluorescence technique, initial angiogenesis was observed only within the peritumoral zone. Microvascular sprouting was oriented multidirec tionally rather than directed specifically toward the glioma cells. The newly formed microvessels subse quently branched and interconnected, forming complex microvascular networks in the peri tumoral area that pre sented with red blood cell perfusion (Fig. 1) . In this early phase, the area of the tumor mass was macroscopically characterized by local hyperemia and diapedesis of red blood cells, leading to mUltiple intratumoral hemor rhages. Between days 6 and 10, the area of the glioma mass was completely vascularized, and the yet dormant glioma started to grow steadily. The microvasculature was characterized by a homogeneous angioarchitecture, including a popUlation of microvessels with diameters ranging between 8 and 16 [Lm (Fig. 1) . With the glioma mass rapidly increasing in size between days 14 and 22 , the microangioarchitecture appeared more heteroge- neous and chaotic. During this period, the microvascu lature could be classified into three distinct zones based on microvascular morphologic features: (I) the peritu moral zone comprised a region of high angiogenic ac tivity with multiple capillary sprouts and microvessels measuring 8 to 16 [Lm in diameter (Fig. 2) ; (II) the mar ginal zone of the glioma mass was characterized by an irregular branching pattern of glioma vessels and some enlarged sinusoidal vessel configurations (diameter 20 to 40 [Lm) with heterogeneous blood flow; the angiogenic activity within this zone was dependent on the distance to the glioma center and decreased centripetally (Fig. 2) ; and (Ill) the central zone of the glioma mass revealed only few signs of neovascularization and contained a large amount of microvessels with either sluggish or no blood flow (no contrast enhancement) (Fig. 2) . Through out the whole observation period, neither significant ac cumulation of leukocytes nor leukocyte-endothelial cell interaction was observed within glioma microvessels.
Quantitative analysis revealed that the growth curves for the glioma area and glioma volume were character ized by an initial lag of tumor growth until day 6 after implantation, but subsequently followed linear and ex ponential kinetics, respectively (Fig. 3) . The newly formed glioma microvasculature was not only confined to the labeled tumor mass but exceeded its size through out the entire observation period, reflecting a significant peritumoral, glioma-induced neovascularization (Fig. 3) . By day 22, the area of the glioma mass in general began to exceed the size of the observation window, and the glioma thickness measured approximately 10 mm. Quantitative evaluation of microcirculatory param eters revealed persistent high values for both total and functional vessel length per area within the peri tumoral zone during the whole observation period (Fig. 4A and  B) . In contrast to these peritumoral regions, total and functional vessel length per area within the glioma mar gin and center were lower and regressed, most prominent within the glioma center, over time ( Fig. 4A and B) . As a consequence, the microvasculature of the growing glioma was characterized by a zonal microvascular gra dient with high vascular densities in the peri tumoral zone and low vascular densities in the central zone. Calcula tion of the zonal perfusion indices from the functional and total vessel length per area revealed constant values (45% to 70%) between days 6 and 18 (Fig. 4C ). How ever, on day 22, the marginal and central perfusion index decreased to values between 15% and 40%, indicating a J Cereb Blood Flow Metab. Vol. 18. No.5. 1998 further zone-dependent aggravation of microvascular dysfunction (Fig. 4C) .
The dynamic relation between glioma growth and vas cularization was further analyzed with respect to differ ent tumor zones. Therefore, the functional vessel length per area of each zone was compared with the area cov ered by the glioma mass applying univariate regression analysis. No correlation was observed within the peritu moral and marginal zones of the glioma (Fig. 5A and B) . In contrast, within the central zone, the functional vessel length per area was inversely related to glioma growth (Fig. 5C ).
From days 6 to 14 , mean diameters of the newly formed microvessels revealed no zonal differences. Whereas diameters of peritumoral microvessels persisted over time (diameterda y 6 = 12.8 /-Lm, diameterda y i8 = 12.7 /-Lm), diameters of perfused marginal and central vessels increased during the further observation period (days 14 to 22) by 36% and 60%, re spectively (Fig. 6A ). In parallel, analysis of red blood cell velocities revealed constantly higher values within peritumoral microvessels when compared with the low marginal and central mi crovascular red blood cell velocities (Fig. 6B) . As a con sequence, mean blood flow in peritumoral, marginal, and central glioma microvessels persisted at comparable val ues between days 10 and 18 after glioma cell implanta tion. However, on day 22, blood flow in individual mar ginal and central microvessels finally decreased (Fig.  6C ).
Microvascular permeability
In parallel to the initial microvascular signs of glioma induced neovascularization, a high microvascular perme ability already was detectable within the first days after glioma cell implantation, which accompanied the process of subsequent glioma vascularization as evidenced by a significant peri tumoral edema and microvascular leakage of FITC-dextraniso' Detailed analysis in the mature glioma (days 18 and 22) revealed a strong molecular weight dependence of the microvascular permeability (Table 1) . After injection of Na-fluorescein, a rapid and homogeneous extravasation of the low molecular fluo rescent marker (Mw = 376 ) from the newly formed glioma microvessels was observed. Within a few min utes, the entire glioma microvasculature appeared in a negative contrast. In contrast, extravasation of the mac romolecular markers FITC-dextraniso and FITC dextransoo was markedly retarded and more heteroge neous. Extravasation was characterized by a patchy mi crovascular leakage pattern with areas of both minimal and maximal extravascular fluorescence that was often localized close to each other. Especially in large tumors, leakage in the glioma center appeared reduced when compared with the leakage within the peri tumoral zones. 22 after C6 glioma cell implantation. Areas covered by glioma mass and microvasculature are given as absolute values (left, y axis) and in relation to total size of chamber preparation (right, y axis). Both were analyzed off-line using a computer-assisted image analysis system (CAPIMAGE, Zeintl Software Engineering, Heidelberg, Germany). Volume of glioma mass was calculated from the area covered by glioma mass and the thickness of the glioma mass. Mean ± SD; N = 5 animals; paired Student's t test and Bonferroni probabilities for repeated measurements; *P < 0.05 versus day 6; #P < 0.05 versus area covered by glioma mass.
Histology
Histomorphologic analysis of the established tumor demonstrated an undifferentiated malignant glioma with small, anaplastic tumor cells and nuclear polymorphisms grown on the striated skin muscle and subcutaneous tis sue of the chamber preparation. Both expanding growth and diffusely infiltrative growth into the underlying chamber tissue could be documented. On day 22, evi dence for early glioma necrosis was observed within the center of the tumor mass. Immunohistochemical analysis revealed a weak detection of glial fibrillary acidic protein and strong staining for S-IOO protein. 
DISCUSSION
Like in most tumors beyond a certain size, malignant glioma proliferation depends critically on a high degree of neovascularization to guarantee adequate oxygen and nutritional supply (Folkman, 1990) . The efficacy of the new microvasculature to meet the metabolic demands of the growing tumor is determined by morphologic (i.e., microangioarchitecture, microvascular density, perfusion index, vessel diameter), microhemodynamic (i.e. , micro vascular red blood cell velocity, blood flow rate), and rheologic (i.e., microvascular hematocrit, viscosity, cell deformability, cell aggregation/adhesion) parameters (Jain, 1988) . We have, therefore, developed a novel in vivo approach that allows the repetitive study of the spa tial and temporal relations of malignant glioma-induced neoangiogenesis and tests the functional state of the newly developed glioma microvasculature.
Discussion of model
We have previously used the hamster and mouse dor sal skinfold chamber preparation to investigate the mi crocirculatory phenomena after organ transplantation (Vajkoczy et ai., 1995a (Vajkoczy et ai., ,b, 1997 . Based on these studies, we have further developed this experimental approach to follow angiogenesis and microcirculation during the pro gression of malignant glioma. Using a multiple fluores-cent labeling technique, this model allows for the repeti- with studies applying invasive postmortem techniques.
....
C
(2) In contrast to histologic vessel counts or global per- .;:
c Our model provides direct access to the glioma mass for 0 superfusion studies or invasive measurements (e.g. , tis-100 sue Po 2 , interstitial pressure). However, this model also has some limitations. The glioma investigated in this preparation is based on a transplantable cell line. Thus, it may respond differently I. (Coomber et aI. , 1988 ; MiJ1auer et aI. , 1994 ; Abramov itch et aI. , 1995) . The rationale for transplanting gliomas subcutaneously is based on the hypothesis that the graft rather than the surrounding host tissue dictates the pro cess of neovascularization as well as the manifestation of glioma microvascular characteristics and endothelial fu nction. Accordingly, ultrastructural analyses of glio mas implanted into brain and muscle demonstrated that glioma vessels differed significantly from host vessels but not from each other with respect to vessel morpho logic features and permeability, regardless of host tis sues, which suggests comparability of cerebral and ex tracerebral implantation sites (Coomber et aI. , 1988) . In addition, the fi ndings of the current experiments are con sistent with the re sults of previous histologic studies on gliomas that were implanted into the brain and were vascularized within a similar time period (i.e., 14 days after tumor cell injection; Deane et aI. , 198 1) . The use of the dorsal skinfold chamber model in the athymic nude mouse, presented here, may be further lim ited because it does not permit studying the lymphocytic infiltration of the tumor because of immunoincompe tence of the animal. This might be of particular signifi cance, since C6 gliomas, like other experimental brain tumors, provoke a specific immunologic response, in cluding infiltration of lymphocytes and macrophages (Morioka et aI. , 1992; Whittle et aI. , 1996 ) . However, by means of injecting ex vivo fluorescently labeled lympho cytes or subpopulations of lymphocytes, our model may have the advantage of enabling separate study of the role of distinct lymphocytic fu nctions in the glioma-related immunologic response. The intravital microscopic ap proach would then allow visualization and quantification of infiltration kinetics and distribution of these cells .
Discussion of results
Time course and mechanisms of neovasculariza tion. The processes of glioma growth and glioma vascu larization were studied immediately after cell implanta tion and were divided into three stages: in stage I, the avascular stage (day 0 to day 6) was characterized by a lag in glioma growth and by initial glioma-induced an giogenesis within the host tissue; in stage 2, the early phase of glioma vascularization (day 6 to day 14 ), a glioma microvasculature with a homogeneous popula tion of micro vessels was found established and, in par allel, glioma cells started to proliferate; and in stage 3 (day 14 to day 22), the microvasculature of the large tumors revealed a clear spatial division. Although a high angiogenic activity and thus functional vessel length per area was observed within the peritumoral region (i.e., where the tumor grows and expands), vascularization and microvascular perfusion progressively failed within the tumor center.
In the literature, three basic morphologic mechanisms of angiogenesis have been proposed: vascular sprouting, elongation of host vessels, and inosculation (i.e., anasto mosis between preexisting host and tumor vessels) (Schoeffel, 1962; Ausprunk et aI., 1975 ) . Whereas the latter mechanism might be significant in the advanced stage of glioma vascularization, both vascular sprouting from preexisting host vessels and newly formed glioma vessels, as well as elongation of host vessels, may occur early in glioma growth. In fact, these mechanisms could be observed as soon as on day 2 after cell implantation. The glioma-induced sprouting during the following days was chaotic, multidirectional, and differed significantly from the classic-radially and unidirectional-sprouting, as described for muscular and corneal wound healing (Schoefl, 1962) . The formation of peritumoral, multidi rectionally growing microvascular networks thus could be interpreted as a consequence of this aberrant sprout ing.
The process of glioma vascularization is thought to be mediated by angiogenic growth factors (e.g., acidic and basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor [VEGF/ VPF]). Hypoxia or nutritional deficiency have been iden tified as major stimuli for their release from the glioma mass (Ikeda et aI. , 1995 ; Shweiki et aI., 1995 ) . The find ing of an angiogenic and microvascular gradient in the late vascular stage seems to be contrary to the fi nding that the expression of VEGF/VPF is particular abundant in glioma cells surrounding necrotic areas within the tu mor center (Plate et aI. , 1994) . This obvious spatial dis crepancy between the release of angiogenic stimuli and the site of angiogenic activity might be best explained by an increased interstitial pressure in the tumor center dur ing glioma growth and angiogenesis, resulting in a cen trifugal pressure gradient and radial convective transport of angiogenic molecules to the glioma periphery (Jain and Baxter, 1988) . Characteristics of glioma microcirculation. Accord ing to a microcirculatory model by Intaglietta and Zwei fach (1974) , tissue perfusion Q (in mLi lOO g/mm) is determined by the following equation:
where D represents mean vessel diameter; RBCV, mean red blood cell velocity ; L, median vascular length ("" functional vessel length per area) ; and S, vascular spac ing (mean distance between microvessels). The number 6000 converts perfusion to milliliters per 100 g per minute. Thus, this equation suggests several potential mechanisms to maintain glioma blood flow, including a recruitment of unperfused microvessels, a dilation of in dividual microvessels, and an increase of red blood cell velocity. In fact, the current study identifies a widening of individual glioma vessels as the major mechanism to compensate for the progressive decrease of vessel length per area within the growing glioma tissue. The appear ance of necrotic areas in the tumor center on day 22, however, suggests that this compensatory potential is only limited. As a consequence, progressive angiogenic deficits and perfusion failure might lead to localized ar eas of poor oxygenation, even within small gliomas (400 mm 3 ). This is of clinical importance since a low P0 2 has been shown to render tumor cells resistant to adjuvant treatment modalities (Degner and Sutherland, 1988) .
Mechanisms of microvascular hyperpermeability.
The formation of glioma-associated vasogenic edema is a major determinant of morbidity and mortality in glioma patients. This phenomenon has been attributed to an in creased microvascular permeability after the secretion of VPFIVEGF by glioma cells (Strugar et a!., 1995 ) . Sev eral ultrastructural examinations aimed at identifying the morphologic structures underlying this increased micro vascular permeability. It is now well established that glioma vessels do not have blood-brain barrier charac teristics (Stewart et aI., 199 1). Endothelial fenestrations, open intercellular junctions, and vesicular-vacuolar or ganelles have been discussed as the morphologic basis for the absence of a blood-glioma barrier (Deane and Lantos, 198 1) . The observed leakage of tracer molecules with a wide range of size (376 < Mw < 500 ,000 ) clearly confirms the absence of a blood-glioma barrier for the newly formed microvasculature. However, it cannot be concluded from the current experiments which of these morphologic structures are responsible for the leakage of the different test molecules. Nevertheless, individual ex travasation kinetics might suggest distinct transport mechanisms for low and high molecular tracers. Thus, it might be hypothesized that leakage of small molecules is facilitated by intercellular gaps and fenestral diaphragms (Roberts and Palade, 1997) , and that extravasation of circulating macromolecules takes place by vesicular vacuolar organelles (Kohn et aI., 1992) .
In summary, the current study demonstrates that intra vital microscopic study is a versatile technique to assess the complex relation of malignant glioma growth, vas cularization, and microcirculation. In our understanding, the potentials and the advantages of the proposed model in the dorsal skinfold chamber preparation of nude mice by far outweigh its disadvantages. We propose that this model enables us to gain further insight into the basic mechanisms of glioma angiogenesis, as well as to de velop and elucidate novel concepts of anti vascular glioma therapy.
